CRIT BIT CORNER

When “More Pressor” Isn't the Answer

57yo Male presented with profound septic shock from acute cholangitis.

He had a complex history, including:

• MASLD cirrhosis status post liver transplant
• Prior biliary anastomotic strictures
• Chronic kidney disease
• Diabetes
• Hypertension
• OSA
• Atrial fibrillation
• Heart failure

IR placed a percutaneous biliary drain for source control. However, full source control was difficult because biliary sludge and stones could not be completely cleared during the procedure.

Even after fluids, broad antimicrobials, stress-dose steroids, source control efforts, and multiple vasopressors, he remained in profound vasodilatory shock.

Before methylene blue, he was on:

• Levophed: 0.46 mcg/kg/min
• Vasopressin: 0.03 units/min
• Angiotensin II: 60 ng/kg/min

After one dose of methylene blue at 2 mg/kg, his pressor needs improved significantly:

• Levophed decreased to 0.08 mcg/kg/min
• Vasopressin stayed at 0.03 units/min
• Angiotensin II decreased to 30 ng/kg/min

Methylene blue did not “fix” the sepsis.

It did not replace antibiotics, source control, CRRT, steroids, or ongoing ICU support.

But it did appear to help with one major problem: The patient’s blood vessels were pathologically relaxed, and the usual vasopressor pathways were not enough.

In simple terms: The pipes were too open, and methylene blue helped turn down one of the body’s strongest “relax the pipes” signals.

Where Nitric Oxide Fits In

Nitric oxide, or NO, is a normal signaling molecule.

It is not automatically bad.

In healthy physiology, nitric oxide helps regulate:

• Vascular tone
• Blood flow
• Oxygen delivery
• Microcirculatory perfusion
• Platelet function

One of nitric oxide’s most important jobs is helping blood vessels relax.

When a tissue needs more blood flow, the endothelium can release nitric oxide. Nitric oxide then tells nearby vascular smooth muscle to relax.

That relaxation widens the vessel and increases flow.

That is normal.

The problem in septic shock is that inflammation can push this pathway into overdrive.

Instead of controlled, local vasodilation, the body develops widespread vasodilation.

That contributes to:

• Low SVR
• Hypotension
• Worsening perfusion
• Vasopressor resistance
• Multipressor shock

Deeper Dive into NO Pathway

Nitric oxide is small and diffuses easily.

After it is made by the endothelium or inflammatory pathways, it moves into nearby vascular smooth muscle.

Once inside the smooth muscle cell, nitric oxide activates an enzyme called soluble guanylate cyclase, or sGC.

sGC then increases cyclic guanosine monophosphate, or cGMP.

cGMP promotes smooth muscle relaxation.

The pathway looks like this:

• Inflammation increases nitric oxide.
• Nitric oxide enters vascular smooth muscle.
• Nitric oxide activates soluble guanylate cyclase.
• Soluble guanylate cyclase increases cGMP.
• cGMP decreases smooth muscle contraction.
• The vessel relaxes. SVR drops.
• MAP falls.

This is the key physiology.

Nitric oxide does not just “relax vessels” in a vague way.

It activates a specific intracellular pathway that tells vascular smooth muscle to stop contracting.

Why Add Methylene Blue?

The patient already had medications trying to constrict the vessels.

But the nitric oxide-cGMP pathway was still strongly telling the vessels to relax.

That creates a mismatch:

• Pressors are saying: “Constrict.”
• Nitric oxide/cGMP is saying: “Relax.”
• The patient remains vasodilated.
• Pressor needs keep climbing.

Methylene blue works differently.

It does not simply add another squeeze signal.

It helps block the relaxation signal.

Back to the Case...

Before methylene blue:

• Levophed: 0.46 mcg/kg/min
• Vasopressin: 0.03 units/min
• Angiotensin II: 60 ng/kg/min

Patient received 250mg (2mg/kg) Methylene Blue IVPB over 30 minutes.

2 hours after a single dose (2mg/kg) of Methylene Blue:

• Levophed: 0.08 mcg/kg/min
• Vasopressin: 0.03 units/min
• Angiotensin II: 30 ng/kg/min

This was not because the infection suddenly disappeared.

It was not because the source control issue suddenly became irrelevant.

It was likely because one major driver of vasoplegia was interrupted.

The nitric oxide-cGMP pathway was pushing the vessels toward relaxation. Methylene blue helped turn down that pathway, making the vascular system more responsive to the pressors already being used.

The Pulse Ox Trap

Methylene blue can interfere with pulse oximetry.

This is one of the biggest bedside issues.

Pulse oximeters estimate oxygen saturation using light absorption. Methylene blue is a dye, so it can interfere with the wavelengths used by the pulse ox.

The result:

• The SpO₂ may read falsely low.

This can be alarming, especially in an already critically ill patient.

The patient may also look blue or cyanotic because methylene blue can discolor the skin and body fluids.

That creates a bedside trap:

• The patient looks blue.
• The pulse ox drops.
• Everyone worries the patient is suddenly more hypoxic.
• But the reading may be artifact from methylene blue.

This does not mean ignore the pulse ox.

It means verify the oxygenation.

If the SpO₂ Drops After Methylene Blue, Ask:

• Did the patient actually clinically deteriorate?
• Is the pulse ox waveform reliable?
• Did ventilator pressures change?
• Did oxygen requirements increase?
• Did breath sounds change?
• Did the patient become harder to ventilate?
• Did blood pressure or rhythm worsen?
• Is there an ABG or co-oximetry value?
• Could this be methylene blue interference?

The safest response is not panic.

The safest response is also not dismissal.

The safest response is verification.

If true hypoxemia is possible, escalate.

But remember:

• After methylene blue, pulse ox may underestimate true oxygen saturation.

Blue Skin and Blue-Green Urine

Methylene blue can discolor:

• Skin
• Urine
• Body fluids
• Mucous membranes

Blue-green urine can be expected.

Blue skin discoloration can happen.

This can worry family members and staff who did not know methylene blue was given. Be sure to include in handoff that Methylene Blue was administered and provide appropriate education to family.

The Big Takeaway

In septic shock, sometimes the problem is not just that the patient needs more vasopressor. Sometimes the problem is that the vascular smooth muscle is being strongly told to relax.

Nitric oxide is one of the body’s major relaxation signals for blood vessels. In normal amounts, it helps regulate perfusion. In septic shock, inflammatory activation can drive excessive nitric oxide signaling. Nitric oxide activates soluble guanylate cyclase, increases cGMP, and promotes vascular smooth muscle relaxation. The result is vasodilation, low systemic vascular resistance, hypotension, and escalating vasopressor needs.

Methylene blue helps by interrupting this pathway. It inhibits nitric oxide synthase and guanylate cyclase, decreasing the nitric oxide-cGMP relaxation signal. This can help the vessels regain tone and become more responsive to other vasopressors.

For the bedside nurse, methylene blue should trigger two thoughts at the same time:

• First, this is a rescue-style adjunct being used because vasoplegia is severe.
• Second, the patient may look blue and the pulse ox may lie.

The nurse’s role is to monitor the hemodynamic response, interpret oxygenation carefully, anticipate discoloration, watch for adverse effects, and communicate clearly so the team understands what is physiology, what is medication effect, and what is true clinical deterioration.